Webinars » CGT » In Vivo CAR-T Webinar | Industrialization of In Vivo CAR-T Therapy Development | ProBio CDMO

Webinar - The Industrialization of In Vivo CAR-T Therapy Development

in vivo CAR-T webinar

CAR-T therapies have revolutionized blood cancer treatment, but traditional ex vivo manufacturing remains costly and time-consuming. Next-generation in vivo CAR-T is set to change the game, driven by two delivery platforms: LVV (viral) and LNP (non-viral). Join our online webinar to explore how LVV and mRNA-tLNP are accelerating the industrialization of in vivo CAR-T therapies.

Chunling Xuan
Director, LVV PD, ProBio
Jiang Xu
Head of LNP formulation, ProBio

Time	Topic
15:30-16:15	*Lentiviral Vector Process Development for In Vivo* CAR-T: Key Points and Core Challenges** Dr. Chunling Xuan, Director, LVV PD, ProBio Insights into process development challenges. Key considerations in quality control and consistency. Regulatory expectations and technical strategies for compliance.
16:15-17:00	*mRNA-tLNP for In Vivo* CAR-T: Challenges and Solutions** Dr. Jiang Xu, Head of LNP formulation, ProBio Practical experience in developing CMC processes for mRNA-tLNP. Analytical method development and optimization. Latest biological data and findings from experimental validation.

Related service: LVV Drug Product One-Stop Solution, RNA-tLNP One-Stop Solution

Available materials

First Name*

Last Name*

Country/Region*

Email Address*

Phone Number

Company Name*

Interest*

When do you need the service?*

Validate Code*

Latest Webinars

Find More Cell & Gene Therapy Categories